Come up with a name for your new list and we'll add to it:
cCam Biotherapeutics was acquired by
Merck & Co. on July 28, 2015.
cCam Biotherapeutics, founded in 2010, is focused on the discovery and development of novel immunotherapies to treat cancer. The company's lead product, CM-24, is a Phase 1, first-in-class humanized a…